Amundi’s Definitive Healthcare DH Stock Holding History

Amundi’s Portfolio DH Stock Details DH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-7,531	Closed	-$70.5K	–	2014
2023 Q4	$70.5K	Hold	7,531	–	–	﹤0.01%	1836
2023 Q3	$51.2K	Hold	7,531	–	–	﹤0.01%	1871
2023 Q2	$82.8K	Hold	7,531	–	–	﹤0.01%	1808
2023 Q1	$76.7K	Sell	7,531 -1,009	-12%	-$11.9K	﹤0.01%	1809
2022 Q4	$106K	Buy	8,540 +2,684	+46%	+$34.5K	﹤0.01%	1594
2022 Q3	$96K	Hold	5,856	–	–	﹤0.01%	1560
2022 Q2	$143K	Buy	+5,856	New	+$125K	﹤0.01%	1397

Other funds holding DH

Advent International Boston, Massachusetts $17.7B AUM 5.23% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Amundi's DH Position: Q1 2024 in Review

Amundi sold out of Definitive Healthcare (DH) in Q1 2024, closing a stake of 7,531 shares — an estimated $70.5K sold.

Amundi first reported a position in DH in Q2 2022 and held it in 7 quarters. The position peaked at $143K in Q2 2022. 144 funds tracked by Wall St. Rank hold DH as of Q1 2024.

Amundi reported no remaining Definitive Healthcare position as of Q1 2024 after selling out during the quarter.
Amundi sold 7,531 Definitive Healthcare shares in Q1 2024, an estimated $70.5K.
Amundi first reported a position in Definitive Healthcare in Q2 2022 and held it in 7 quarters.
Amundi's Definitive Healthcare position peaked at $143K in Q2 2022.
144 funds tracked by Wall St. Rank held Definitive Healthcare as of Q1 2024.

Based on Amundi's 13F filing for Q1 2024, filed 15 May 2024.